Chlorpheniramine Maleate Market

Chlorpheniramine is used for allergic rhinitis, cold and sinusitis and allergic skin diseases such as urticaria, allergic drug rash or eczema, angiospermic edema, insect bite caused skin pruritus.

Chlorpheniramine Maleate Market contains market size and forecasts of Chlorpheniramine Maleate in Global, including the following market information:

Global Chlorpheniramine Maleate Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Chlorpheniramine Maleate market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Injection Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Chlorpheniramine Maleate include AstraZeneca, Beijing Pacific Pharmaceutical, Gedeon Richter, GlaxoSmithKline, Merck, Renhetang Pharmaceutical, Sanofi, Guangdong Nanguo Pharmaceutical and Henan Jiushi Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Chlorpheniramine Maleate companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Chlorpheniramine Maleate Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Chlorpheniramine Maleate Market Segment Percentages, by Type, 2021 (%)

Injection

Syrup

Tablets

Powder

Global Chlorpheniramine Maleate Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Chlorpheniramine Maleate Market Segment Percentages, by Application, 2021 (%)

Allergy

Hay Fever

Common Cold

Itchy Throat/Skin

Rhinitis

Other

Global Chlorpheniramine Maleate Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Chlorpheniramine Maleate Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Chlorpheniramine Maleate revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Chlorpheniramine Maleate revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

AstraZeneca

Beijing Pacific Pharmaceutical

Gedeon Richter

GlaxoSmithKline

Merck

Renhetang Pharmaceutical

Sanofi

Guangdong Nanguo Pharmaceutical

Henan Jiushi Pharmaceutical

Huarun Shuanghe Pharmaceutical

Huazhong Pharmaceutical

Jilin Bainianhanke Pharmaceutical

Jilin Province Fuertai Pharmaceutical Co. , Ltd

Linfen Baozhu Pharmaceutical

Shaanxi Bikang Pharmaceutical Group Holding Co. , Ltd.

Shanghai Hefeng Pharmaceutical

Shanghai Modern Pharmaceutical

Shanghai Shangyao Xinyi Pharmaceutical

Shanghai Xudong Haiyin Pharmaceutical

Sinopharm Group

Suicheng Pharmaceutical

Tianjin Jinyao group

Wuhu Kangqi Pharmaceutical

Xinxiang Changle Pharmaceutical

Yunnan Botanical Pharmaceutical